INTRODUCTION {#S1}
============

Autophagy is a homeostatic metabolic mechanism responsible for bulk degradation of cellular molecules and organelles ([@R19]; [@R25]). Although key for cancer initiation and progression ([@R34]), the involvement of autophagy in the stromal compartment, and in particular in cancer-associated fibroblast (CAF) activation, has been investigated to a limited extent. Autophagy-activating conditions, such as low nutrients, increased reactive oxygen species (ROS) ([@R27]), and hypoxia ([@R21]), are often found in cancer stroma ([@R35]). In this context, a reverse Warburg effect concept was introduced, whereby activation of stromal autophagy and mitophagy by hypoxia ([@R21]), senescence ([@R2]), and autophagy effectors ([@R3]) leads to a glycolytic switch producing high-energy intermediates, such as ketones and lactate, which impinge on cancer cells promoting tumor growth and metastasis ([@R22], [@R23]).

The CSL/RBPJκ (CSL) protein, a transcriptional repressor converted by NOTCH into an activator, is key for negative control of CAF activation. Deletion of Csl in the mesenchymal skin compartment of mice or *CSL* down-modulation in primary human dermal fibroblasts (HDFs) results in the activation of a CAF phenotype ([@R8]; [@R29]). We have shown that *CSL* loss in HDFs leads to up-regulation of the pro-autophagy kinase ULK3, which is responsible for CAF activation and concomitantly activates autophagy and a mitophagy-associated glycolytic switch ([@R7]).

The adaptor protein sequestosome 1 (p62/SQSTM1) plays a key role in the autophagic process, functioning as cargo for specific proteins, including key transcription factors like SMADs and nuclear factor κB (NF-κB), to be degraded in autophagosomes, with p62 being degraded in the process ([@R26]). p62 is down-regulated in the stroma of several cancer types, and its down-modulation has been implicated in the metabolic reprogramming of stromal CAFs through an mTORC1/Myc pathway regulating interleukin-6 (IL-6) production ([@R33]). In the liver, loss of p62 activates stromal stellate cells, resulting in higher inflammation and fibrosis due to impaired vitamin D receptor (VDR) signaling with p62 functioning in this context as a transcriptional co-regulator ([@R5]). Little is known about the control of CSL protein turnover, particularly in the tumor microenvironment. We report here a so far unsuspected interplay between p62 and CSL. p62 and CSL proteins associate physically, and upon induction of autophagy, CSL is down-modulated in stromal fibroblasts through a p62-dependent mechanism. This is functionally significant, because CSL and p62 are concomitantly down-modulated in clinically derived CAFs and increased CSL stabilizes p62, decreasing the expression of autophagic genes.

RESULTS {#S2}
=======

Loss of Csl repressive function in mouse dermal fibroblasts and HDFs leads to CAF activation ([@R8]; [@R29]). Concomitantly, we showed that *CSL* down-modulation increases HDF autophagy, mitophagy, and associated metabolic reprogramming ([@R7]). Previous evidence reported that pro-carcinogenic stimuli such as ultraviolet A rays (UVAs) and smoke extract exposure, which induce autophagy ([@R30]; [@R31]), similarly down-regulate CSL ([@R24]). Using specific experimental conditions activating different types of autophagy, we determined that all inducers of autophagy affected CSL protein levels. Conditions such as serum starvation, inhibition of mTOR activity, and mitochondria uncoupling down-regulated CSL protein levels in HDFs, as seen by immunofluorescence and immunoblotting ([Figures 1A and 1B](#F1){ref-type="fig"}). Decreased CSL protein levels are not a secondary consequence of reduced transcription, because *CSL* mRNA was not concomitantly down-modulated after these treatments ([Figure 1C](#F1){ref-type="fig"}), and they are functionally significant, because we observed a simultaneous upregulation of CAF effector genes such as cyclooxygenase-2 (*PTGS2*), tenascin-C (*TNC*), and *IL6* ([Figure 1D](#F1){ref-type="fig"}).

To assess whether CSL protein downmodulation is a consequence of increased autophagy, we employed several comple-mentary approaches. 3-methyladenine (3MA) blocks early steps of the autophagic process by targeting type III phosphatidyli-nositol 3-kinases ([@R13]). Treatment of HDFs with this inhibitor counteracted the down-modulation of CSL by various inducers of autophagy while resulting in an accumulation of p62/SQSTM1 (p62), a cargo protein that is degraded by autophagic flux ([@R13]) ([Figure 2A](#F2){ref-type="fig"}). As a more specific approach, we targeted the *ATG5* gene, which is essential for autophagosome elongation ([@R13]; [@R17]). Down-modulation of the CSL protein by the various inducersof autophagy was suppressedin HDFswith smallhairpin RNA (shRNA)-mediated down-modulation of *ATG5*, as well as in mouse embryo fibroblasts (MEFs) with *Atg5* gene disruption ([Figures 2B and 2C](#F2){ref-type="fig"}). Thus, pro-autophagic stimuli down-modulate CSL protein levels through a mechanism requiring the autophagic machinery.

p62 has a cargo function for several transcription factors ([@R9]; [@R12]), and an attractive possibility was that it physically associates with CSL. Proximity ligation assays (PLAs) provide a sensitive method for detection of protein-protein associations at the cellular level ([@R32]). We found punctate signals (*puncta*) resulting from the juxtaposition of anti-CSL and anti-p62 antibodies in HDFs (Figures [3A](#F3){ref-type="fig"} and [S1A](#SD1){ref-type="supplementary-material"}), with the number of these puncta being significantly reduced by *CSL* silencing as a specificity control (Figures [3B](#F3){ref-type="fig"} and [S1B](#SD1){ref-type="supplementary-material"}). More directly, we found that endogenous p62 and CSL were recovered by co-immunoprecipitation from HDFs (Figures [3C](#F3){ref-type="fig"} and [S1C](#SD1){ref-type="supplementary-material"}). Similar positive results were obtained after co-immunoprecipitation of the two recombinant proteins, demonstrating a direct interaction between the two ([Figure 3D](#F3){ref-type="fig"}).

The p62 protein contains several functional regions, including an N-terminal oligomerization domain (protein homo/hetero dimerization domain of p62 \[PB1\]), a light-chain 3 (LC3)-interacting region (LIR), and a C-terminal ubiquitinassociation (UBA) domain ([@R9]; [@R26]). Co-immunoprecipitation experiments of HEK293 cells co-transfected with expression vectors for CSL, together with p62 deletion mutants disrupting these various regions ([@R1]), showed that binding of CSL was unaffected by all p62 mutations except the one with a deletion of the 50 amino acid C-terminal domain, more directly implicated in the delivery of proteins to degradation ([@R9]; [@R15]) ([Figure 3E](#F3){ref-type="fig"}).

To assess whether CSL-p62 interaction is of functional importance for CSL degradation, we tested whether p62 is required for CSL down-modulation by autophagy stressors. We found that down-modulation of CSL protein levels by autophagy stressors was suppressed in both HDFs or MEFs with small interfering RNA (siRNA)- or shRNA-mediated *p62* silencing ([Figures 4A and 4B](#F4){ref-type="fig"}). Similarly, CSL down-modulation by autophagy stressors was blocked in MEFs with *p62* gene disruption ([Figures 4C and 4D](#F4){ref-type="fig"}). The preceding findings are of likely clinical significance for HDF to CAF activation, in which we showed that CSL down-modulation induces autophagy ([@R7]). Immunoblot analysis showed parallel down-modulation of CSL and p62 levels in a set of skin squamous cell carcinoma (SCC)-derived CAF strains versus non-matched HDFs ([Figure 5A](#F5){ref-type="fig"}).

Functionally, increased CSL expression by lentiviral vector infection of HDFs resulted in concomitantly enhanced p62 levels under basal conditions and after autophagy activation by serum starvation, in both the presence and the absence of bafilomycin A1, which prevents lysosomal acidification step of the autophagic flux ([Figure 5B](#F5){ref-type="fig"}). On this line, we found that *CSL* overexpression was paralleled by the suppression of three autophagy marker genes ([Figure 5C](#F5){ref-type="fig"}) that we have shown to be up-regulated by CSL loss in HDFs ([@R7]).

Decreased p62 is causative to CAF activation in multiple systems ([@R5]; [@R33]). We found that CSL overexpression in patient-derived CAFs similarly stabilized the levels of p62 ([Figure 5D](#F5){ref-type="fig"}), consistent with the reversion of CAF phenotype after *CSL* overexpression ([@R29]).

CSL protein expression is negatively controlled by autophagy through a mechanism involving a direct CSL-p62 protein association. In turn, by decreasing the autophagic process, CSL functions as a positive determinant of p62 expression levels, pointing to a self-reinforcing loop that could be targeted in CAF activation.

DISCUSSION {#S3}
==========

In tumor stroma, CAFs affect all aspects of tumor evolution ([@R4]; [@R10]). Thus, targeting of CAFs represents an emerging alternative therapeutic approach ([@R6]). Although several programs leading to the activation of CAFs have been elucidated, little is known about the impact of the microenvironment on the turnover of key CAF regulators. CSL, a transcriptional repressor that mediates NOTCH signaling, suppresses the gene expression programs, leading to stromal senescence and CAF activation ([@R8]; [@R29]). We report here that increased autophagy increases CSL turnover, which is functionally relevant, because it is associated with enhanced CAF effector expression. We find a so far unsuspected interplay between CSL and p62 signaling leading to CAF activation. p62 and CSL proteins associate directly, and upon induction of autophagy, CSL is down-modulated in stromal fibroblasts through a p62-dependent mechanism. In CAFs, both CSL and p62 proteins are down-modulated as a reflection of increased autophagy in these cells ([@R7]).

Autophagy-enhancingconditions,suchasROS([@R27]), hypoxia ([@R21]), and nutrient starvation ([@R23]), can create a pro-tumorigenic microenvironment rich in metabolic precursors directed from the stroma to the tumor ([@R20]; [@R35]). As for CSL ([@R8]; [@R29]), p62 protein and RNA levels are reduced in the stromal compartment of several cancer types, with p62 deficiency, resulting in CAF activation ([@R33]). An unanswered question was whether CSL and p62 are functionally connected. p62 is a multifaceted adaptor protein involved in functions ranging from nutrient or amino acid sensing and oxidative stress response to selective autophagy ([@R12]). The cargo function of this protein is mediated by its ubiquitin-association (UBA) domain, which is involved in target protein recognition, and by its LIR, required for autophagosome recruitment and degradation. p62 binds to key transcription factors like SMADs, NRF2, and NF-κB to be degraded in autophagosome, with p62 being degraded in the process ([@R9]). We have found that CSL is down-modulated by autophagy, because genetic or pharmacologic inhibition of the process blunts CSL degradation. Upon autophagy activation, the mechanism involves the physical and direct association to the UBA domain of p62 adaptor. Another protein with key transcription regulatory functions, GATA4, was shown to similarly go through autophagic turnover mediated by p62 binding ([@R11]).

Transcriptional control of autophagy is an area of active investigation ([@R18]; [@R28]) and autophagy and mitophagy have been implicated in CAF conversion ([@R7]; [@R10]; [@R23]). Besides being negatively regulated by autophagy, down-modulation of CSL expression---as can result from exogenous pro-carcinogenic stimuli such as UV or smoke exposure ([@R24])---can by itself induce or reenforce the autophagic process ([@R7]). An interesting possibility is that autophagy acts at multiple levels in CAF activation, initiating gene expression by increasing CSL turnover and by causing a cell-autonomous metabolic switch upon the increase of autophagy and mitophagy after CSL loss of function ([@R7]). Counteracting CSL down-modulation can stabilize p62, thereby enhancing the nuclear transcription regulatory function that this protein plays in negative control of CAF activation ([@R5]; [@R33]).

STAR★METHODS {#S4}
============

KEY RESOURCES TABLE {#S5}
-------------------

  REAGENT or RESOURCE                                                                          SOURCE                         IDENTIFIER
  -------------------------------------------------------------------------------------------- ------------------------------ ------------------------------
  Antibodies                                                                                                                  
                                                                                                                              
  Rabbit monoclonal anti CSL                                                                   Cell Signaling                 Cat\# 5313; AB_2665555
  Rabbit monoclonal anti LC3B                                                                  Cell Signaling                 Cat\# 3868; AB_2137707
  Rabbit monoclonal anti b-ACTIN                                                               Cell Signaling                 Cat\# 5125; AB_1903890
  Rabbit monoclonal anti SQSTSM/p62                                                            Sigma                          Cat\# P0067; AB_1841064
  Rabbit anti CSL                                                                              [@R29]                         N/A
  Rabbit anti GFP                                                                              Santa Cruz                     Cat\# 8334; AB_641123
  Rabbit anti ATG5                                                                             Epitomics                      Cat\# 3167--1; N/A
  Mouse monoclonal anti SQSTSM/p62                                                             Santa Cruz                     Cat\# 28359; AB_628279
  Mouse monoclonal anti FLAG                                                                   Sigma-Aldrich                  Cat\# F3165; AB_259529
  Mouse monoclonal anti GAPDH                                                                  Santa Cruz                     Cat\# 47724; AB_627678
                                                                                                                              
  Biological Samples                                                                                                          
                                                                                                                              
  HDFs: discarded skin samples of abdominoplasty patients at Massachusetts General Hospital    Dermatology, MGH, Boston, MA   N/A
  CAFs: surgically excised discarded skin SCC samples                                          Dermatology, MGH, Boston, MA   N/A
                                                                                                                              
  Chemicals, Peptides, and Recombinant Proteins                                                                               
                                                                                                                              
  Recombinant human CSL                                                                        Origene                        Cat\# TP760429
  Recombinant human p62                                                                        Enzo                           Cat\# ENZ-PRT120--0050
  Bafilomycin A1                                                                               EMD Millipore                  Cat\# 19--149
  3-methyladenine                                                                              Sigma-Aldrich                  Cat\# M9281--100MG
  mTOR inhibitor KU0063794                                                                     Calbiochem                     Cat\# CAS 938440--64-3
  Carbonyl cyanide m-chloro-phenyl-hydrazone (CCCP)                                            Calbiochem                     Cat\# CAS 555--60-2
  Puromycin                                                                                    Calbiochem                     Cat\# CAS 58--58-2
  Doxycycline                                                                                  Calbiochem                     Cat\# CAS 24--390-14--5
  Hiperfect                                                                                    Quiagene                       Cat\# 301707
  Lipofectamine 2000                                                                           Invitrogene                    Cat\# 11668019
  Liberase TL                                                                                  Roche                          Cat\# 5401020001
  Flag-MAGNETIC beads                                                                          Sigma-Aldrich                  Cat\# M8823--1ML
  Donkey anti rabbit peroxidase conjugated                                                     Thermo Fisher                  Cat\# NA934V
  Donkey anti mouse peroxidase conjugated                                                      Thermo Fisher                  Cat\# NA931V
  Donkey anti rabbit Alexa 488                                                                 Invitrogen                     Cat\# A 21206
  Phalloidin RITC                                                                              Sigma-Aldrich                  Cat\# P1951--1MG
                                                                                                                              
  Critical Commercial Assays                                                                                                  
                                                                                                                              
  Proximity ligation assay - Duolink                                                           Sigma-Aldrich                  Cat\# DUO92101
                                                                                                                              
  Experimental Models: Cell Lines                                                                                             
                                                                                                                              
  MEFs Atg5 +/+                                                                                [@R17]                         N/A
  MEFs Atg5 −/−                                                                                [@R17]                         N/A
  MEFs p62 +/+                                                                                 [@R14]                         N/A
  MEFs p62 −/−                                                                                 [@R14]                         N/A
  HEK293                                                                                       ATCC                           RRID: SCR_001672
  Human primary dermal fibroblasts                                                             This paper                     SAN1
  Human primary dermal fibroblasts                                                             This paper                     SAN2
  Human primary dermal fibroblasts                                                             This paper                     SAN3
  Human primary dermal fibroblasts                                                             This paper                     SAN4
  Human primary dermal fibroblasts                                                             This paper                     SAN5
  Human primary dermal fibroblasts                                                             This paper                     SAN6
  Human primary dermal fibroblasts                                                             This paper                     SAN8
  Human cancer associated fibroblasts                                                          This paper                     CAF1
  Human cancer associated fibroblasts                                                          This paper                     CAF2
  Human cancer associated fibroblasts                                                          This paper                     CAF3
  Human cancer associated fibroblasts                                                          This paper                     CAF4
  Human cancer associated fibroblasts                                                          This paper                     CAF16
                                                                                                                              
  Oligonucleotides                                                                                                            
                                                                                                                              
  siRNA scrambled control -Silencer                                                            Ambion                         Cat\# 4390846; ID: N/A
  siRNA targeting p62 -Silencer                                                                Ambion                         Cat\# 4427037; ID: 16962
  siRNA targeting CSL -Silencer                                                                Ambion                         Cat\# 4392420; ID 24886
  shRNA empty control N/A                                                                      Sigma-Aldrich                  pLKO_TRC001
  shRNA targeting p62 CCGGCCCTTTGTCTTGTAGTTGCATCTCGAGATGCAACTACAAGACAAAGGGTTTTTG               Sigma-Aldrich                  TRCN0000098615
  shRNA targeting ATG5 CCGGGCCAAGTATCTGTCTATGATACTCGAGTATCATAGACAGATACTTGGCTTTTTG              Sigma-Aldrich                  TRCN0000099430
  Oligonucleotides for PCR are listed in [Table S1](#SD1){ref-type="supplementary-material"}                                  
                                                                                                                              
  Recombinant DNA                                                                                                             
                                                                                                                              
  GFP-p62                                                                                      [@R1]                          N/A
  GFP-p62 ΔPB1                                                                                 [@R1]                          N/A
  GFP-p62 ΔUBA                                                                                 [@R1]                          N/A
  GFP-p62 ΔLIR                                                                                 [@R1]                          N/A
  CSL-FLAG                                                                                     [@R29]                         N/A
  Myc-CSL inducible                                                                            [@R29]                         N/A
                                                                                                                              
  Software and Algorithms                                                                                                     
                                                                                                                              
  IMAGEJ                                                                                       NIH                            <https://imagej.nih.gov/ij/>
  Prism 7                                                                                      Graphpad software              <https://www.graphpad.com>

CONTACT FOR REAGENT AND RESOURCE SHARING {#S6}
========================================

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Gian Paolo Dotto (<paolo.dotto@unil.ch>)

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S7}
======================================

Human samples {#S8}
-------------

Normal human skin samples and samples of squamous cell carcinoma (SCC) were obtained at the Department of Dermatology, Massachusetts General Hospital, as discarded parts not needed for diagnosis. All samples were processed as approved by the MGH Institutional Review Board. The age/stage, sex and gender identity of the subjects was not available.

Cell culture and primary cell derivation {#S9}
----------------------------------------

All the cells were routinely grown at 37 in a 5% CO2 incubator in DMEM Cellgro\#15--017CV, 10%FBS, 2mM Glutamine and 100U/ml penicillin, 100mg streptomycin. All cellular strains used were routinely checked for the absence of mycoplasma.

Normal HDFs were prepared from discarded skin samples of abdominoplasty patients at Massachusetts General Hospital (Boston, Massachusetts, USA) as in ([@R29]). Each HDF strain was identified by letters recognizing the operator and a number, which are indicated in the different panels and listed in the [Key Resources Table](#S5){ref-type="sec"}. For derivation of cancer associated fibroblasts (CAFs), surgically excised discarded skin SCC samples were dissociated with Liberase TL (Roche) as in ([@R7]). The isolated CAFs strains were validated in immunofluorescence as vimentin positive and pan Keratin negative. Each strain derived from a patient was identified with a progressive number, which is indicated in the different panels and listed in [Key Resources Table](#S5){ref-type="sec"}. The information on sex/gender/age was not available.

METHOD DETAILS {#S10}
==============

Cell manipulation {#S11}
-----------------

RNA-mediated gene interference experiments were carried out with Silencer™ siRNA oligos from Ambion and Hiperfect reagents (QIAGEN) (for *CSL* and *p62*), or, by using shRNA gene targeting lentiviral vectors from Sigma Aldrich (for p62 and ATG5), as previously described ([@R7]; [@R29]). The lentiviral vectors (in the pLKO.1 backbone) were packaged using PEI (Sigma) in actively growing 293 HEK cells in combination with pMD2.G/ /Rev/RRE plasmids. Virus containing supernatants were collected 72h from transfection filtered to eliminate cell particulates and used to infect HDFs or MEFs in the presence of 10mg polybrene (Millipore). Cells were subsequently used for the experiments after puromycin selection (1μg/ml) for 48--72 h.

HDFs strains stably infected with a doxycycline-inducible lentiviral vector for Myc-tagged CSL in parallel with empty vector control ([@R29]) were treated for 3 days plus/minus doxycycline (200 ng ml^−1^) before autophagy induction for 24h and analysis.

The list of the antibodies, reagents, cell lines, MEFs, HDFs, CAFs, siRNA and shRNA sequences used are in the [Key Resources Table](#S5){ref-type="sec"}.

Gene Expression analysis {#S12}
------------------------

Conditions for reverse transcription and quantitative cDNA amplification (RT--qPCR) have been previously reported ([@R7]; [@R29]). Total RNA was extracted using a Quiagene kit, and 750 ng reverse transcribed with iScript cDNA synthesis kit (BioRad). Quantitative amplification was performed with a Roche real-time thermocycler and the expression of the genes was normalized with BETA ACTIN. *The oligonucleotides used in qPCR are provided in* [Table S1](#SD1){ref-type="supplementary-material"}.

Autophagy studies, immunofluorescence and immunoblots {#S13}
-----------------------------------------------------

HDFs and MEFs autophagy was activated by incubating the cells in serum free or by adding to the culture medium (10%FBS) 10mM mTOR inhibitor KU0063794 (Calbiochem) or 100nM carbonyl cyanide m-chloro-phenyl-hydrazone (CCCP) mitochondrial uncoupling agent (Calbiochem) for 24h. Western blots and immunofluorescences were performed as in ([@R16]; [@R29]).

Cells for protein analysis were washed in PBS ice cold then lysed in LDS-NuPAGE loading buffer 1x (Invitrogen) with phosphatase and protease inhibitors before separation of the total cell lysates on 4%--12% Bis-Tris gels (Invitrogen). Equal amount was loaded for each sample as assessed with separate Comassie blue stained gels and verified by sequential blotting of the same membrane with a control antibody (TUBULIN, ACTIN or GAPDH, as indicated). For immunofluorescence cells were counted with a haemocytometer and seeded on coverslips. The next day the HDFs or MEFs were treated as indicated to activate autophagy and thus fixed after 20 h with 3% PFA in PBS for the analysis. Phalloidin and DAPI were used to counterstain the cytoskeleton and the nucleus respectively. Slides were mounted with Fluomount-G (Southern Biotech) and analyzed using a Nikon Eclipse TE300 fluorescence microscope.

Immunoprecipitations and protein interaction {#S14}
--------------------------------------------

The co-immunoprecipitation of p62 and CSL was performed from HDFs using a native lysis buffer (150mM NaCl, 50mMTris pH7, 1% Triton X-100, 10mM PMSF and PIC, Roche), in the presence of 4mg of anti CSL or NRS (Cell Signaling) and 40 μl Protein G magnetic beads (Life Technologies) for 4h at 4C. The complexes were washed 4 times in lysis buffer and eluted with SDS-running buffer. For the interaction of CSL with p62 wt and deletion constructs, 3mg of CSL-Flag and 3μg of GFP tagged wild-type, ΔPB1, ΔUBA and ΔLIR region ([@R1]) were transfected in 293 cells using PEI method. After 48h the cells were lysed in native lysis and the immunoprecipitation carried out using 40μl Flag-MAGNETIC beads (Sigma). The complexes were washed 5 times in lysis buffer before the sequential immunoblotting with GFP (Santa Cruz) and Flag M2 (Sigma) antibodies.

For the recombinant protein interaction, 500 ng of recombinant CSL (Origene) and p62 (Enzo) were diluted in 500 ml PBS and incubated 2h at 4C on a rotor. The sample was split in two for over night incubation with 1μg of specific antibody against CSL (Cell Signaling) or p62 (Sigma) and non-specific rabbit IgG respectively, as control. 25 μl Dynabeads (Invitrogen) were added for additional 4h at 4°C with rotation. Bait and prey were immunoprecipitated using a magnet and washed 4 times with 500 μl PBS before boiling with sample buffer and western blotting.

Proximity ligation assays ([@R32]) were performed using Duolink PLA kit (Sigma) according to manufacturer's protocol. Briefly, cells were fixed with 4% formaldehyde and permeabilized in 0.1% Triton X-100. After blocking with PLA blocking solution, HDFs were incubated with primary antibody solution containing p62 (Santa Cruz) and CSL (Cell Signaling) antibodies (both from Santa Cruz). After washing with PLA wash buffer, cells were incubated with PLA probes, anti-rabbit PLUS, anti-mouse MINUS, then washed, ligated, amplified by rolling circle amplification. Images were obtained with a Nikon Eclipse Ti confocal microscope.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S15}
=======================================

Data are presented as mean ± SEM, mean ± SD, or as ratio among treated and controls, as indicated in the Figure legends. For gene expression and functional testing assays, statistical significance of differences between experimental groups and controls was assessed by two-tailed unpaired t test, as indicated in the figure legends. A value for p \< 0.05 was considered as statistically significant. For each experiment, two to three separate HDF strains were used in independent experiments. The CAFs from four independent patients were used. The researchers were not blinded and no strain or result was excluded from the analysis.

DATA AND SOFTWARE AVAILABILITY {#S16}
==============================

Unprocessed original image data have been deposited to Mendeley Data and are available at <https://doi.org/10.17632/grw7vdjkdb.1>.
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![Autophagy Down-Modulates CSL Protein\
(A) CSL is down-regulated by autophagy. Immunoblot analysis was performed for four HDF strains that were untreated (untr.), serum starved (s.f.), or treated with the KU0063794 mTOR inhibitor (mTOR-i; 10 μM) or a mitochondria-uncoupling agent (CCCP; 5 μM) for 24 hr to induce autophagy. Blots were sequentially probed with antibodies against CSL, LC3- to monitor autophagic processing, and with anti γ-Tubulin (TUBULIN) or β-Actin (ACTIN), as equal loading. The identifier of the operator and a progressive number classify each primary HDF strain (e.g., SAN3), and a list of all the cells used is provided in [Key Resources Table](#S5){ref-type="sec"}.\
(B) Immunofluorescence analysis with anti-CSL antibodies (green), phalloidin (red), and DAPI (blue) of two HDF strains treated as in (A). Phalloidin and DAPI counterstained the cytoskeleton and the nuclei, respectively. Scale bar, 40 μm.\
(C) Autophagy down-modulates CSL protein independently of its RNA levels. RT-qPCR analysis of *CSL* expression, normalized to *β*-actin, of two HDF strains (SAN4 and SAN5) treated as in (A).\
(D) CSL down-modulation results in the upregulation of CAF effector genes. RT-qPCR analysis of the indicated CAF effector gene expression, normalized to *β*-actin, of two HDF (SAN2 and SAN3) treated as in (A).\
Mean ± SEM; n (experiments) = 3; NS, not significant; \*p ≤ 0.05, two-tailed unpaired t test.](nihms-1508524-f0002){#F1}

![CSL Protein Down-Modulation Requires Autophagy\
(A) Pharmacologic inhibition of autophagy blocks CSL down-modulation. Immunoblot analysis was performed for two HDF strains treated as indicated in [Figure 1A](#F1){ref-type="fig"} for 24 hr and further incubated with 5 mM 3-methyladenine (3MA) for 8 hr to inhibit autophagy, in parallel with vehicle alone (DMEM). The blot was sequentially probed with antibodies against CSL, p62, and β-ACTIN.\
(B and C) Targeting of autophagy-essential gene *ATG5* blocks CSL down-modulation. Immunoblot analysis was performed for two HDFs plus/minus shRNA-mediated *ATG5* gene silencing (B) or for mouse embryo fibroblasts (MEFs) plus/minus *Atg5* gene disruption (+/+ and /) ([@R17]) (C) that were either left untreated (untr.) or treated with various pro-autophagic stimuli as in [Figure 1A](#F1){ref-type="fig"}. Blots were sequentially probed with antibodies against CSL, ATG5, and ACTIN as equal loading.](nihms-1508524-f0003){#F2}

![Endogenous p62 and CSL Proteins Directly Interact in HDFs\
(A and B) Proximity ligation assays (PLAs) for in *situ* detection of CSL and p62 association in HDFs. Assays were carried out in the presence or absence of primary antibodies (A) or with HDFs plus/minus siRNA-mediated *CSL* gene silencing (B) as controls of specificity. Confocal microscopy was used to examine red fluorescence PLA *puncta* with concomitant DAPI staining of nuclei (blue). The white frames indicate the enlarged areas to better show PLA red *puncta.* Shown are representative images and quantification of the average number of puncta per cell, counting at least 30 cells in four fields per conditions. p ≤ 0.05, two-tailed unpaired t test. Scale bars, 10 and 1 μm for enlargements. Additional PLA images of p62 and CSL interaction are provided in [Figures S1A and S1B](#SD1){ref-type="supplementary-material"}.\
(C) Endogenous p62 and CSL proteins interact. Immunoprecipitates from HDFs (strain SAN4) with anti-CSL antibodies and non-immune immunoglobulin Gs (IgGs) were analyzed, together with total inputs by sequential immunoblotting with antip62 and CSL antibodies. IgG light chains (LCs) are indicated. A similar immunoprecipitation in another HDF strain (SAN3) is shown in [Figure S1C](#SD1){ref-type="supplementary-material"}.\
(D) p62 and CSL proteins directly interact. Recombinant CSL and p62 proteins were admixed and incubated for 2 hr before immunoprecipitation with either anti-CSL or anti-p62 antibodies or nonimmune IgGs, followed by immunoblot analysis with anti-p62 antibodies (green) and anti-CSL antibodies (red). IgG heavy chains (HCs) are indicated.\
(E) p62 interaction with CSL requires p62 C-terminal region. Immunoblot analysis showed HEK293 transfected for 48 hr with expression vectors for CSL-FLAG, GFP-p62, and a combination of CSLFLAG and GFP-p62 wild-type (WT) or GFP-p62 constructs with deletions of the N-terminal PB1 region, LIR, and C-terminal UBA region (as indicated in the scheme) ([@R1]). Total lysates were immunoprecipitated with anti-FLAG antibodies, and blots were probed sequentially with anti-GFP and anti-FLAG antibodies. The input totals were analyzed by parallel immunoblotting as control for the level of expression.](nihms-1508524-f0004){#F3}

![Autophagy Down-Modulates CSL Protein through a p62-Dependent Mechanism\
(A and B) Immunoblot analysis of two HDF strains (A) or MEFs (B) plus/minus *p62* silencing by siRNA-mediated (A) or shRNA-mediated (B) RNA interference, either left untreated (untr.) or treated with various pro-autophagic stimuli as in [Figure 1A](#F1){ref-type="fig"}. Blots were sequentially probed with antibodies against p62, CSL, and ACTIN antibodies.\
(C) Immunoblot analysis with antibodies against p62, CSL, and ACTIN antibodies of MEFs plus/minus p62 gene disruption (−/− and +/+) ([@R14]). Cells were either left untreated (untr.) or treated with various pro-autophagic stimuli as in [Figure 1A](#F1){ref-type="fig"}.\
Immunofluorescence analysis with CSL antibodies and DAPI of *p62* +/+ and *p62* −/− MEFs treated as in [Figure 1A](#F1){ref-type="fig"}.](nihms-1508524-f0005){#F4}

![CSL Down-Modulation Is Linked to Higher Autophagy in CAFs\
(A) p62 and CSL levels are concomitantly downmodulated in CAFs. Left: immunoblot with anti-p62, anti-CSL, and anti-ACTIN antibodies in nonmatched HDF and CAF strains. Right: immunoblot quantifications, n (HDF) = 2, n (CAF) = 4; \*p \< 0.05, two-tailed unpaired t test. Each derived HDF strain was marked by an operator identifier and progressive numbers (SAN1 and SAN2). CAF strains were marked only by a progressive number (CAF1--CAF4) ([@R7]).\
(B) *CSL* overexpression stabilizes p62 protein. Immunoblot analysis showed HDFs (SAN3) stably infected with a lentivirus for doxycycline-inducible CSL expression ([@R29]), plus/minus doxycycline (200 ng/mL) for 3 days, under basal conditions and after autophagy activation by serum starvation (24 hr). Bafilomycin A1 was added for 2 hr to monitor autophagic flux ([@R13]). The arrow indicates the stabilized high-molecular p62 band upon CSL induction. The blots were sequentially probed with antibodies against p62, LC3, CSL, and ACTIN.\
(C) CSL overexpression inhibits autophagy geneexpression. RT-qPCR analysis with the indicated genes, normalized to *β*-actin, in two HDF strains stably infected with an inducible CSL-expressing lentivirus, plus/minus CSL induction as in (B).\
(D) *CSL* overexpression stabilizes p62 in CAFs. Immunoblot analysis showed antibodies against p62, CSL, and GAPDH of two patient-derived CAF strains (CAF1 and CAF16) expressing a doxycycline-inducible CSL and plus/minus (200 ng/mL) for 2 days.\
Numbers refer to densitometry quantification of p62 in CSL-overexpressing versus noninduced control CAFs (folds of induction).](nihms-1508524-f0006){#F5}

###### Highlights

-   Autophagy down-modulates CSL/RBPJκ in stromal fibroblasts

-   CSL degradation by autophagy requires interaction with p62 adaptor

-   CSL down-modulation by autophagy induces cancer-associated fibroblast (CAF) genes

-   CSL overexpression in CAFs stabilizes p62 and represses expression of autophagy genes
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